304 results about "Clostridiales" patented technology

The invention discloses a probiotic-polyphenol nanoparticle colon-targeted co-delivery system as well as a preparation method and application thereof, and belongs to the field of biological medicines. The FCPs and hyaluronic acid (HA) are combined through non-covalent interaction, so that the hydrogel has colon targeting property and mucosal adhesion at the same time, and delivery of probiotics is facilitated. The hydrogel (HF) based on polysaccharide has good biocompatibility, and can be used for effectively encapsulating the probiotics and the natural products. Then, the PDA-TH NPs and BA are incorporated into the polysaccharide chain network of HF, and finally the BA-HF-PDAT targeted co-delivery system is constructed. The BA (at) HF-PDAT targeted co-delivery system can protect BA from serious gastrointestinal stress, and is jointly assembled with PDT-TH NPs to realize dual slow release of thymol (Thy), so that the treatment effect of BA and Thy is improved, and the BA (at) HF-PDAT targeted co-delivery system contributes to treatment of clostridium difficile infection (CDI).

The invention discloses a fermentation medium for regulating and controlling a clostridium aerovorans target product and a fermentation method of the clostridium aerovorans target product. The medium comprises a basic component and a regulating component, the basic components comprise ammonium chloride, potassium chloride, magnesium sulfate heptahydrate, sodium chloride, monopotassium phosphate, yeast powder, calcium chloride dihydrate, sodium selenite, nickel chloride hexahydrate, biotin, folic acid, pyridoxine hydrochloride, thiamine, riboflavin, nicotinic acid, D-calcium pantothenate, cobalamin, para aminobenzoic acid and lipoic acid; the adjusting component comprises sodium tungstate, ferrous sulfate and sodium molybdate, sodium tungstate and ferrous sulfate have a forward adjusting effect on increasing the yield of acetic acid, ethanol and butanol in the target product, and sodium molybdate has a reverse adjusting effect on the target product. By optimizing the proportion of trace elements in the culture medium, the clostridium metabolism efficiency is improved, synthesis of a target product is regulated and controlled, and the method is particularly suitable for industrial production of acetic acid, ethanol, butanol and the like.

The invention discloses a clostridium corpse strain and application thereof. The preservation number of the clostridium cadaveris J038 strain of the clostridium cadaveris J038 strain is CGMCC (China General Microbiological Culture Collection Center) NO. 35440, and the clostridium cadaveris J038 strain of the clostridium The clostridium corpse J038 strain is separated from pig manure for the first time, and 4-hydroxyphenylpropionic acid is produced by metabolism of the clostridium corpse J038 strain. In addition, the invention further provides application of the clostridium corpse in preparation of 4-hydroxyphenylpropionic acid, and when the clostridium corpse is adopted to prepare 4-hydroxyphenylpropionic acid, the clostridium corpse has the advantages of being small in environmental pollution, high in sustainability, precise, green, efficient and the like; the yield is high, and the increasing requirements of the fields of medicine, food, agriculture and the like on the 4-hydroxyphenylpropionic acid can be met.

The invention discloses an application of some functional genes in improving the performance of clostridium for synthesizing ethanol by utilizing one-carbon gas fermentation, wherein overexpression genes NCBI (National Center for Biotechnology Information) are CLJUc04490, CLJUc25060, CLJUc06990, CLJUc22650 and / or CLJUc07720, and expression of inhibition genes CLJUc09160 and / or CLJUc23840 can be used for improving the autotrophic growth capability and the ethanol synthesis yield of clostridium Yangdall when the clostridium Yangdall is fermented by utilizing C1 gas; therefore, the economical efficiency of the clostridium yangdall fermentation is improved.

The invention discloses clostridium butyricum as well as a culture method and application thereof, belongs to the field of feed additives, and aims to solve the problems that a controllable fattening period is shortened and the efficacy of the clostridium butyricum cannot be completely exerted due to the fact that a wide range of clostridium butyricum needs a relatively long adaptation period for an endogenous intestinal environment of an animal. The clostridium butyricum from the North Naa Biotechnology Co., Ltd. Is cultured by simulating an animal endogenous environment in vitro, and after the clostridium butyricum which completely adapts to animal endogenous is obtained, the screened animal endogenous clostridium butyricum is coated by adopting a coating technology, so that the clostridium butyricum is not damaged by a strong acid environment in an animal stomach bag; the clostridium butyricum strain has the advantages that the clostridium butyricum strain can be used for preparing animal endogenous clostridium butyricum, a large quantity of animal endogenous clostridium butyricum can reach intestinal tracts and be released, and the animal endogenous clostridium butyricum can quickly adapt to animal intestinal environment due to higher adaptability of the strains, and can quickly form efficient colonization and functional expression under the condition of almost no adaptation period. The feed additive can be used as a biological feed additive.

The invention discloses a method and a system for producing high-purity medium-chain fatty acid (MCFA) based on waste molasses two-stage regulation fermentation. Comprising the following steps: (1) diluting waste molasses, then adding a compound enzyme agent of pectinase, beta-glucanase and cellulase, and coupling microwave to assist treatment; (2) inoculating the pretreated waste molasses with a composite flora containing a clostridium kluyveri mutant strain and a Megasphaera elsdeni engineering bacterium, and carrying out a fermentation treatment on the waste molasses, wherein the composite flora contains the clostridium kluyveri mutant strain and the Megasphaera elsdeni engineering bacterium; (3) sequentially performing two-stage dynamic regulation and control fermentation on the waste molasses inoculated with the composite flora through a pH-stat control strategy to realize efficient conversion from butyric acid to hexanoic acid / octanoic acid; and (4) a hydrophobic hollow fiber membrane module is adopted to realize on-line removal of the product, and the inhibition effect of the product is relieved. According to the technology, the yield of the MCFA produced from the waste molasses reaches 0.45 g / g COD, the cost is reduced by 68% compared with that of a traditional substrate, and a new way is provided for recycling of sugar manufacturing waste.

The invention discloses saccharomyces boulardii, a culture and a preparation method and application of the saccharomyces boulardii. The preservation number of the strain is CCTCC (China Center for Type Culture Collection) NO: M 20252633. The preparation method comprises the following steps: preparing saccharified liquid by taking white spirit vinasse or brewer's grains as a main raw material and adopting a high-temperature alkali treatment and composite enzymolysis process, inoculating strains for liquid-state high-density fermentation, carrying out solid-liquid separation on fermentation liquor, taking a liquid phase, and carrying out spray drying. According to the method, high-value utilization of the waste vinasse is realized, and the production cost is remarkably reduced. The obtained culture is rich in viable bacteria and active small peptides, and has the characteristics of strong tolerance, wide antibacterial spectrum and the like. As a feed additive, the feed additive can effectively reduce the diarrhea rate of piglets, inhibit clostridium perfringens and prawn vibrios of broilers, and improve the oxidation resistance and production performance of animals.

Provided is a growth inhibitor for Clostridioides difficile. A growth inhibitor for Clostridioides difficile, comprising killed Enterococcus faecalis. Also provided are a parenteral pharmaceutical preparation, a bactericide, a disinfectant, an antibacterial agent, a sanitizer or a detergent for inhibiting the growth of Clostridioides difficile.

The invention relates to a special microbial agent fertilizer for konjak, and aims to break through the industrial bottlenecks of high incidence of soft rot, damage caused by waterlogging stress and glucomannan synthesis obstacles in konjak cultivation. According to the core technical scheme, the activity of soft rot fungus pectinase is inhibited in a targeted mode through clostridium butyricum, and efficient polymerization of gulcomannan molecular chains is driven in cooperation with a hydroxyproline precursor provided by fish meal; a sulfonic acid group of biochemical potassium fulvate is used for blocking waterlogging free radical poison, and a brown sugar-trehalose carbon source ratio is optimized to stabilize cell osmotic pressure in an expansion period; and a supplementary application mechanism based on a precipitation threshold (greater than or equal to 10mm) and a copper preparation application isolation regulation are established in a matched manner. According to the technology, the three-effect synergy that the soft rot prevention and control rate is larger than 90%, the glucomannan viscosity improvement rate is larger than 70% and the waterlogging survival rate is larger than 85% is achieved, and the core restriction of high-yield and high-quality production of the konjak is systematically solved.

The application belongs to the technical field of biology and relates to a Clostridium butyricum engineering strain for improving butyric acid synthesis through a coenzyme A transferase pathway as well as a construction method and application of the Clostridium butyricum engineering strain. Clostridium tyrobutyricum The application expresses a butyryl coenzyme A:acetic acid-coenzyme A transferase gene from Clostridium tyrobutyricum Ctcat1 A coenzyme A transferase (CoAT) pathway is constructed, the pathway synthesizes butyric acid by taking acetic acid as a substrate, therefore, the content of acetic acid in a fermentation product is greatly reduced, and the butyric acid yield is significantly improved.

Compounds to treat various infections, including infections caused by Clostridioides difficile, particularly the compounds α-methylene and α-aminomethyl lactones, lactams, iminolactones, and iminolactams, thiolactones, thionolactones, thiolactams, and thionolactams; pharmaceutical compositions; and methods for treating those infections.

This invention relates to a method for detecting the activity of a toxin produced by bacteria of the families Peptostreptococcaceae or Clostridiaceae using mass spectrometry, which comprises the following steps: a) providing a planar surface suitable for mass spectrometry measurement, with attached affinity molecules; b) incubating the planar surface from step a) with the substrate of the toxin to be detected, to bind the substrate to the affinity molecules; c) subsequently incubating the planar surface from step b) with a sample in which the active toxin is to be detected, in the presence of a modification compound, and incubating it for a time sufficient for the substrate to react with the modification compound in the presence of the active toxin, if present in the sample, to form a modified substrate if the active toxin is present in the sample; d) removing the remnants of the sample; e) subjecting the (modified) substrate on the planar surface to matrix-assisted laser desorption / ionization, ionizing it and subsequently measuring the mass spectrum of the (modified) substrate; f) analyzing the measured mass spectrum, such that if the measured mass spectrum corresponds to the non-modified substrate, the active toxin is not present, and if the measured mass spectrum corresponds to the modified substrate or a mixture of the modified and non-modified substrate, then the active toxin is present in the sample. The invention further relates to a device for the soft landing of affinity molecule ions onto a planar surface suitable for mass spectrometry for carrying out step a) of the above method.

The invention discloses a micropterus salmoides intestinal function feed additive based on composite synergy and application thereof, and belongs to the technical field of feed additives. The feed additive for improving the intestinal function of the largemouth bass comprises the following raw materials: clostridium butyricum, tributyrin, aspergillus niger and a plant source carrier. The invention provides a compound feed additive capable of remarkably improving the growth performance of the largemouth bass, improving the digestive enzyme activity of the intestinal tract and optimizing the intestinal barrier, and the compound feed additive can remarkably improve the weight gain rate and the specific growth rate of the largemouth bass, remarkably improve the digestive enzyme activity of the intestinal tract of the largemouth bass and maintain the integrity of the tissue structure of the intestinal tract. Compared with a single additive, the compound additive shows a better synergistic gain effect in the aspect of comprehensive effects, has important value for promoting research, development and practical application of novel feed additives of micropterus salmoides, has good popularization and application prospects, and is expected to bring remarkable economic benefits to the breeding industry.

The present invention is directed to cell-free methods, such as those for determining the clostridial neurotoxin activity of a composition, determining whether or not a composition comprises clostridial neurotoxin polypeptides, and / or determining whether or not clostridial neurotoxin polypeptides or portions thereof comprised in a composition comprise an activity-altering property. The invention is also directed to an isolated capture substrate for a clostridial neurotoxin, use of the same, therapeutic or cosmetic clostridial neurotoxin compositions, and methods for producing the same.

The present invention provides a prophylactic or therapeutic composition for graft-versus-host disease (GVHD). There is provided a prophylactic or therapeutic composition for GVHD, which comprises bacteria belonging to any genus selected from the group consisting of the following genera: Blautia, Clostridium, unclassified Clostridiales, Actinomyces, Parabacteroides, Lachnoclostridium, Bacteroides, Faecalibacterium, unclassified Lachnospiraceae, Roseburia, Ruminococcus, unclassified Firmicutes, Dorea, Phascolarctobacterium, Sutterella, Megamonas, Collinsella, Eubacterium, and Coprococcus, etc., or any combination of bacteria belonging to these genera.

The invention provides a clostridium thermocellum engineering strain with a high nitrogen utilization rate. NitR regulatory protein is precisely overexpressed in the engineering strain; the precise overexpression is as follows: the expression level of the regulatory protein NitR is 1.2-2.0 times that of a wild type. A chassis strain of the strain is clostridium thermocellum GB2 with a glucosidase expression cassette on a genome, and the clostridium thermocellum GB2 is an engineering strain for expressing BGL in clostridium thermocellum DSM1313. The inventor accidentally finds that when the expression level of the regulatory protein NitR is controlled to be 1.2-2.0 times that of a wild type, the growth ability and biomass accumulation of the engineering strain under the nitrogen-deficient condition are remarkably improved, so that the utilization efficiency of a nitrogen source is increased, and an unexpected technical effect is achieved. The invention further provides a construction method of the clostridium thermocellum engineering strain and application of the clostridium thermocellum engineering strain in saccharification of lignocellulose raw materials. The engineering strain is particularly suitable for saccharification treatment of low-nitrogen-content lignocellulose raw materials (such as corn straw and corn cob residues), the saccharification efficiency is improved while the nitrogen source adding cost is remarkably reduced, and the engineering strain has important significance on industrial application.

The application discloses a three-stage linkage hydrogen production method based on kitchen waste, and relates to the technical field of biological enzymes, and comprises the following steps: step I, pretreatment; step II, dark fermentation: feeding the material treated in step I into a dark fermentation tank, inoculating Clostridium beijerinckii with the preservation number of ATCC NO.35702; step III, photo fermentation: feeding the first fermentation liquor into a photo fermentation tank, inoculating Rhodopseudomonas palustris with the preservation number of CGMCC 1.2180, adding 50 mg / L-100 mg / L MoFe nanoparticles, and collecting the gas produced in the fermentation. The three-stage linkage of the synergistic pretreatment, dark fermentation and photo fermentation realizes the efficient and stable conversion of the kitchen waste into hydrogen.

The invention belongs to the technical field of biology, and relates to a clostridium butyricum engineering strain for improving butyric acid synthesis through a coenzyme A transferase pathway, and a construction method and application thereof. According to the method disclosed by the invention, a coenzyme A transferase (CoAT) pathway is constructed by expressing butyryl coenzyme A: acetic acid-coenzyme A transferase gene Ctcat1 from clostridium tyrobutyricum, and the pathway is used for synthesizing butyric acid by taking acetic acid as a substrate, so that the content of acetic acid in a fermentation product is greatly reduced, and the yield of butyric acid is remarkably increased.

The present invention relates to a Korean microbiome-derived Clostridium butyricum strain having anti-obesity efficacy and a use thereof. The strain has an excellent effect of reducing the body weight and adipose tissue weight of experimental animals compared to a control group (strain-untreated) under high-fat diet conditions, has an excellent effect of reducing the content of total cholesterol, triglycerides, low-density lipoprotein (LDL), leptin, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) in serum, and has an excellent effect of reducing blood glucose and increasing the content of glucagon-like peptide-1 (GLP-1) in an oral glucose load test, and is thus expected to be effectively used as an ingredient in a composition for preventing, alleviating, or treating obesity and metabolic diseases caused by obesity.

This invention provides a strain derived from Clostridium difficile (Clostridium difficile) Clostridioides difficile This invention relates to mutants of glutamate dehydrogenase and their preparation, including single-site, two-site, or multi-site mutants. The invention effectively solves the problems of inactivity or low activity of glutamate dehydrogenase in the biocatalytic transformation of 2-carbonyl-4-(hydroxymethylphosphono)butyric acid as a substrate, and provides a continuous chemical method for the synthesis of 2-carbonyl-4-(hydroxymethylphosphono)butyric acid using a microchannel reactor throughout the entire process.

The invention discloses a clostridium butyricum preparation for preventing and treating porcine reproductive and respiratory syndrome and application of the clostridium butyricum preparation, and belongs to the technical field of microbial fermentation feed. According to the invention, the clostridium butyricum with the preservation number of CCTCC NO: M 20231636 is subjected to activation culture, seed culture and high-density fermentation culture to prepare the clostridium butyricum preparation, and the effect of the clostridium butyricum preparation in prevention of PRRSV infection is developed. Experimental results show that when the clostridium butyricum preparation is added into a pig complete feed, the positive infection rate of the porcine reproductive and respiratory syndrome of a pig herd can be effectively reduced, the death number of the pig herd is remarkably reduced, and the clostridium butyricum preparation has outstanding prevention and treatment effects. The clostridium butyricum preparation provided by the invention is free from drug resistance and toxic and side effect risks, has the advantages of low cost, high safety, environment friendliness and the like, and has great significance in benefit improvement of the live pig breeding industry.

The invention belongs to the technical field of biological medicines, and particularly relates to a composition for improving a cognitive function as well as a preparation method, a product and application of the composition. The composition is prepared by taking soybean meal, whey protein peptide powder and bovine bone collagen peptide powder in a mass ratio of 1: 3: 2 as peptide source raw materials, matching the peptide source raw materials with AMY001, lactobacillus plantarum LP-90 and clostridium butyricum (3: 1: 1) compound strains, and carrying out enzyme production self-hydrolysis by bacillus amyloliquefaciens, peptide-bacterium anaerobic synergistic fermentation and sodium alginate-HPMC-CPP composite carrier embedding. According to the present invention, the hippocampus Abeta1-42 protein can be cleared, the BDNF content can be increased, the IL-6 expression inhibition multi-mechanism synergistic effect can be achieved, the memory improvement rate and the Abeta1-42 clearance rate are high, and the cognitive impairment can be significantly repaired. The composition is high in stability and bioavailability, controllable in preparation process and suitable for development of food and health care products for improving the cognitive function and medicines for preventing or assisting in improving diseases related to cognitive impairment.

The invention relates to a preparation method of a water-free biological fermentation material, and belongs to the technical field of biological fermentation. The method comprises the following steps: carrying out micro-crushing and heat treatment on substrates such as soymilk residues, fruit residues and / or sweet potato residues with natural water content of 60-85%; carrying out expanding culture by adopting a composite strain consisting of lactic acid bacteria, saccharomycetes and optional bacillus subtilis and clostridium butyricum; carrying out dry-wet mixing on the pretreated substrate and the bacterial liquid according to the mass ratio of (10-30): 1 to form a dry-wet mixture; carrying out primary fermentation for 24-72 hours at the temperature of 30-38 DEG C, and then carrying out constant-temperature finished product fermentation in a breathable container. According to the invention, a dry-state fermentation system which is completely free of free water is constructed, efficient degradation of a substrate and synergistic generation of a functional product are realized while efficient expression of a strain is ensured, and good fermentation stability is achieved.

A method for treatment of one or more toxin(s) in a subject, that includes administering to the subject a therapeutically effective amount of a serine protease that enzymatically cleaves certain toxins. Also, a method for preventing disease progression in a subject infected by Clostridioides difficile (CD), diarrhea, or infectious colitis, which includes administering to the subject a therapeutically effective amount of the protease. The protease retains its activity up to 65° C. Treatment with the protease in mice infected with CD conferred a 10-fold survival benefit compared to mice infected with CD and untreated.

The present invention is directed to cell-free methods, such as methods for determining the clostridial neurotoxin activity of a composition, determining whether a composition contains a clostridial neurotoxin polypeptide, and / or determining whether a clostridial neurotoxin polypeptide or portion thereof contained in a composition contains an activity-altering characteristic. The present invention is also directed to isolated capture substrates for clostridial neurotoxins, uses thereof, therapeutic or cosmetic clostridial neurotoxin compositions, and methods for making same.

The invention relates to the technical field of biological detection, in particular to an LAMP (loop-mediated isothermal amplification) detection kit for clostridium difficile tcdA and tcdB. The kit comprises a specific LAMP primer group, an LAMP amplification reaction mixed solution, a lysis solution, a positive reference substance, a negative reference substance and an operation instruction. The system is based on a loop-mediated isothermal amplification (LAMP) principle, nucleic acid detection of toxin-producing genes tcdA and tcdB of clostridium difficile is realized under the condition of 61-65 DEG C, and a detection result is judged through colorimetric change of HNB or a fluorescence signal; according to the system, an amplification reaction can be completed without a thermal cycler, the reaction time is about 50 minutes, and rapid detection can be realized on site; the method disclosed by the invention has the advantages of high sensitivity, strong specificity, simplicity and convenience in operation and low equipment dependence, and is suitable for detecting the toxin-producing gene of the clostridium difficile in medical institutions, primary laboratories and public health monitoring.

The invention relates to the technical field of feed additives, and particularly discloses a feed mildew removing agent and a preparation method thereof. The feed mildew removing agent provided by the invention is prepared from the following raw material components: bacillus microcapsules, clostridium butyricum microcapsules, modified montmorillonite, saccharomyces cerevisiae cell walls and a vinasse fermentation synergist. Through the design of coating micro-capsules of bacillus and clostridium butyricum, the survival rate of flora in the transportation and storage stages is improved, and effective mold removal is promoted by cooperating with modified montmorillonite toxin adsorption; furthermore, the vinasse fermentation synergist prepared on the basis of bacillus subtilis-lactobacillus two-step fermentation is endowed with the functions of integrating nutrition supply, toxin inhibition and flora regulation and control, and various substances generated by fermentation not only directly improve nutrition for animals, but also help flora to improve the intestinal toxin removal efficiency; and clostridium butyricum is matched to reduce the local pH of the intestinal tract, inhibit the proliferation of toxin-producing mould and reduce the intestinal tract colonization of the mould.

The invention relates to the technical field of biological medicine, in particular to a composition for blocking formation of phage treatment tolerance and application of the composition. The composition comprises a folium ilicis purpurea ethyl acetate extraction active component and a clostridium perfringens specific bacteriophage, the folium ilicis purpurea ethyl acetate extraction active component is prepared from the following components in percentage by mass: 8 to 15 percent of protocatechuic acid and 5 to 10 percent of ethyl gallate, and the mass ratio of the protocatechuic acid to the ethyl gallate is (1.5 to 1) to (2.5 to 1); the clostridium perfringens specific bacteriophage is a virulent bacteriophage capable of specifically cracking a clostridium perfringens NetB toxin positive strain. According to the invention, the shallow thought that the existing compounding technology only pursues synergistic sterilization is subverted, and a deep synergistic mode of bacteriophage splitting attack and folium ilicis purpurea component disintegration bacterial defense program is proposed and verified for the first time. And the formation of tolerance is fundamentally blocked, so that a more thorough and more lasting treatment effect is realized, and the comprehensive production performance of animals is accidentally and greatly improved on the basis of the treatment effect.

The invention discloses a method for improving the continuous fermentation efficiency of clostridium aerovorans. According to the method, a continuous fermentation system in which a first fermentation tank and a second fermentation tank are connected in series is adopted, clostridium aerovorans is used as a production strain, and synthesis gas is used as a raw material. The method is characterized in that after thalli in a first fermentation tank enter a stable phase, a continuous process is started, the dilution degree is optimized to be 0.15-0.7, the nutrient concentration of a supplemented fresh culture medium is adjusted to be 0.65-1 time of the standard concentration, and growth and metabolism of the thalli are cooperatively regulated. According to the invention, the thallus delay period of the second fermentation tank is effectively shortened, decayed thalli are replaced, the overall flora activity is enhanced, the continuous fermentation period is obviously prolonged to more than 200 hours, the yields of ethanol and butanol are greatly improved, meanwhile, foaming in the fermentation process is effectively inhibited, and the system is simple in structure, convenient to operate and suitable for industrial application.

Antibody-based binding agents derived from human and camelid immunoglobulins are described, as well as strains of yeast engineered to secrete the binding agents, and methods of treating and preventing Clostridium difficile infections using the engineered strains of yeast. These binding agents recognize and bind with specificity to Clostridium difficile toxin A and / or toxin B and in some cases exhibit toxin neutralizing activity. The binding agents include camelid VHH peptide monomers, linked groups of VHH peptide monomers, VHH peptide monomers joined to antibody Fc domains, and VHH peptide monomers joined to IgG antibodies.